Atrial fibrillation in hypertrophic cardiomyopathy - A contemporary mini-review
- PMID: 35584711
- DOI: 10.1016/j.hjc.2022.05.002
Atrial fibrillation in hypertrophic cardiomyopathy - A contemporary mini-review
Abstract
Hypertrophic cardiomyopathy (HCM) represents the most common genetically inherited cardiovascular disorder and a leading cause of heart failure and sudden cardiac death. Atrial fibrillation (AF) is the most common arrhythmia encountered in HCM patients, primarily due to the process of left atrium dilatation and remodeling. Its presence typically leads to progressive functional decline, increased frequency of heart failure hospitalizations, and increased thromboembolic risk. In this mini-review, we summarize the contemporary data on AF pathophysiology, risk factors, and management in HCM patients suffering from AF.
Keywords: Arterial thromboembolism; Atrial fibrillation; Hypertrophic cardiomyopathy.
Copyright © 2022 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflicts of Interest The authors declare no conflict of interest.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical